Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates safety, tolerability, pharmacokinetics, and preliminary efficacy of BTX-9341 in advanced or metastatic breast cancer and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BTX-9341

Snippet

Sponsor: Biotheryx, Inc. | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING